- Version
- Download 4
- File Size 228.56 KB
- File Count 1
- Create Date July 26, 2017
- Last Updated April 20, 2023
A female infant born at 38+4 weeks gestation with a birth weight of 3170 grams. The mother was G1P0. She was admitted for induction at 38+4 weeks gestation because of pregnancy induced hypertension. On rupture of the membranes there was blood loss and on CTG a fetal tachycardia was seen. An emergency caesarean section was performed and during the resuscitation the infant had profound bradycardia with no spontaneous breathing effort. After 5 inflation breaths the heart rate increased and after 10 minutes she was breathing spontaneously but with an irregular breathing pattern. Apgar scores were 2, 5 and 7 at 1, 5 and 10 minutes respectively. She was admitted to the neonatal unit in an outlying hospital where she stabilized quickly. Her first glucose level was 3.6 mmol/L and she had a capillary sample lactate of 11.2 mmol/L. Around 12 hours after birth she had an incident of bradycardia, followed by a drop of oxygen saturation and thereafter clinical seizure like activity involving both arms and legs. A loading dose of phenobarbitone (20 mg/kg) was given. Ten hours later she developed clinical seizures again with movements of her right arm and a drop in oxygen saturation. Another dose of phenobarbitone was given and she was transported to our NICU for further cerebral monitoring and investigation.
Please download following .PDF to view the full clinical case study.
Dr. Linda van Rooij
Department of Neonatology
File | |
---|---|
014485A_CFM-OBM_Case-Study__EN-Perinatal Stroke.pdf |
Upcoming Events
September
07sepAll Day09Pan-Asian Consortium for Treatment and Research in ALS (PACTALS)Melbourne, Australia
Time
September 7, 2025 - September 9, 2025 (All Day)(GMT+10:00)
Location
Melbourne
Melbourne,Australia
Register NOW
07sepAll Day10American College of Emergency Physicians (ACEP)Salt Lake City, UT
Time
September 7, 2025 - September 10, 2025 (All Day)(GMT-06:00)
Location
Salt Lake City, USA
Register NOW
15sepAll Day19Neurocritical Care Society (NCS)Montreal, Canada
Time
September 15, 2025 - September 19, 2025 (All Day)(GMT-04:00)
Location
Montreal, Canada
Register NOW
Upcoming LIVE eSeminars
September
Event Details
This lecture introduces the development of SCORE-AI/autoSCORE, the first AI system capable of providing comprehensive interpretation of routine EEGs, long-term monitoring EEGs, and ambulatory EEGs. It will explain basic principles
Event Details
This lecture introduces the development of SCORE-AI/autoSCORE, the first AI system capable of providing comprehensive interpretation of routine EEGs, long-term monitoring EEGs, and ambulatory EEGs. It will explain basic principles of AI in EEG analysis, present validation results, and explore future perspectives on integrating AI into clinical practice. The session will conclude with a live demonstration of autoSCORE in action.
Learning Objectives:
- Learn why AI is needed in EEG interpretation and the specific challenges it helps address.
- Gain a basic understanding of AI and deep learning concepts as applied to EEG analysis.
- Discover how SCORE-AI/autoSCORE was developed, validated, and implemented in clinical workflows.
- Understand the potential impact and future role of AI in enhancing EEG interpretation and patient care.
Approved for 1.0 CEU available through ASET
Speakers for this event
-
Dr. Harald Aurlien
Dr. Harald Aurlien
MD
Dr. Harald Aurlien is a clinical neurophysiologist and neurologist with over 20 years of experience in EEG diagnostics and AI development. He is currently a Consultant at the Department of Clinical Neurophysiology, Haukeland University Hospital, Bergen, Norway. Dr. Aurlien is also Chief Medical Officer at Holberg EEG, leading innovations in automated EEG interpretation. He has expertise in EEG standardization (SCORE), international taskforces, and the integration of AI into clinical practice.
MD
Time
September 24, 2025 11:00 am - 12:00 pm(GMT-04:00)